Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2)

BACKGROUND: Anaplastic thyroid cancer (ATC) is one of the most aggressive malignancies in humans, often demonstrating resistance to multimodal therapeutic approaches. The median survival of ATC patients after initial diagnosis was reported to be < 6 months due to the rapid progression of disease...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Onoda, Naoyoshi, Sugitani, Iwao, Higashiyama, Takuya, Hara, Hisato, Ito, Ken-ichi, Kammori, Makoto, Sugino, Kiminori, Suzuki, Shinichi, Toda, Kazuhisa, Yoshida, Akira, Miyauchi, Akira
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4474467/
https://ncbi.nlm.nih.gov/pubmed/26091846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1490-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados